The ultimate microbial composition for correcting Th17/Treg cell imbalance and lipid metabolism disorders in osteoporosis

被引:0
|
作者
An, Fangyu [3 ]
Jia, Xueru [2 ]
Shi, Yangyang [2 ]
Xiao, Xiaolong [1 ]
Yang, Fan [1 ]
Su, Junchang [2 ]
Peng, Xia [1 ]
Geng, Guangqin [2 ]
Yan, Chunlu [1 ]
机构
[1] Gansu Univ Chinese Med, Sch Trad Chinese & Werstern Med, Lanzhou 730000, Gansu, Peoples R China
[2] Gansu Univ Chinese Med, Sch Basic Med, Lanzhou 730000, Gansu, Peoples R China
[3] Gansu Univ Chinese Med, Teaching Expt Training Ctr, Lanzhou 730000, Gansu, Peoples R China
基金
中国国家自然科学基金;
关键词
Intestinal microbiota; Immune regulation; Lipid metabolism; Osteoporosis; BONE-MINERAL DENSITY; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-I; BILE-SALT BIOTRANSFORMATIONS; IGF-BINDING PROTEINS; REGULATORY T-CELLS; VITAMIN-D-RECEPTOR; GUT MICROBIOTA; OSTEOBLAST DIFFERENTIATION; POSTMENOPAUSAL WOMEN;
D O I
10.1016/j.intimp.2024.113613
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteoporosis is a systemic bone disease characterised by decreased bone mass and a deteriorated bone microstructure, leading to increased bone fragility and fracture risk. Disorders of the intestinal microbiota may be key inducers of osteoporosis. Furthermore, such disorders may contribute to osteoporosis by influencing immune function and lipid metabolism. Therefore, in this review, we aimed to summarise the molecular mechanisms through which the intestinal microbiota affect the onset and development of osteoporosis by regulating Th17/ Treg imbalance and lipid metabolism disorders. We also discussed the regulatory mechanisms underlying the effect of intestinal microbiota-related modulators on Th17/Treg imbalance and lipid metabolism disorders in osteoporosis, to explore new molecular targets for its treatment and provide a theoretical basis for clinical management.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Th17/Treg Imbalance and Atherosclerosis
    He, Xin
    Liang, Bo
    Gu, Ning
    DISEASE MARKERS, 2020, 2020
  • [2] Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis
    Roba M. Talaat
    Asmaa Sidek
    Ahmed Mosalem
    Ahmed Kholief
    Inflammopharmacology, 2015, 23 : 119 - 125
  • [3] Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis
    Talaat, Roba M.
    Sidek, Asmaa
    Mosalem, Ahmed
    Kholief, Ahmed
    INFLAMMOPHARMACOLOGY, 2015, 23 (2-3) : 119 - 125
  • [4] T Cell Metabolism: A New Perspective on Th17/Treg Cell Imbalance in Systemic Lupus Erythematosus
    Shan, Juan
    Jin, Hong
    Xu, Yan
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [5] The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice
    Yan, Chao
    Zhang, Bei-Bei
    Hua, Hui
    Li, Bo
    Zhang, Bo
    Yu, Qian
    Li, Xiang-Yang
    Liu, Ying
    Pan, Wei
    Liu, Xiang-Ye
    Tang, Ren-Xian
    Zheng, Kui-Yang
    PLOS ONE, 2015, 10 (11):
  • [6] Role of Th17 cells, Treg cells, and Th17/Treg imbalance in immune homeostasis disorders in patients with chronic obstructive pulmonary disease
    Ma, Ru
    Su, Hongling
    Jiao, Keping
    Liu, Jian
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (02)
  • [7] Th17/Treg Imbalance in Sickle Cell Disease and Hydroxyurea Therapy
    Gilli, Simone
    Pericole, Fernando V.
    Fernandes, Luis Gustavo
    Ribeiro, Karina A. R.
    Castilho, Lilian
    Costa, Fernando Ferreira
    Olalla Saad, Sara T.
    BLOOD, 2011, 118 (21) : 484 - 484
  • [8] Commentary: T cell metabolism: a new perspective on Th17/Treg cell imbalance in systemic lupus erythematosus
    Jin, Jiamei
    Liu, Xiaogu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [9] Lipid metabolism in Th17 cell function
    Kanno, Toshio
    Nakajima, Takahiro
    Miyako, Keisuke
    Endo, Yusuke
    PHARMACOLOGY & THERAPEUTICS, 2023, 245
  • [10] Th17/Treg Imbalance in Malignant Pleural Effusion
    杨卫兵
    叶志坚
    向菲
    张建初
    周琼
    Current Medical Science, 2013, (01) : 27 - 32